scispace - formally typeset
W

Weixing Du

Researcher at Hubei University of Medicine

Publications -  16
Citations -  729

Weixing Du is an academic researcher from Hubei University of Medicine. The author has contributed to research in topics: Medicine & Plasmodium falciparum. The author has an hindex of 6, co-authored 11 publications receiving 235 citations.

Papers
More filters
Journal ArticleDOI

Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy.

TL;DR: The biological functions of immune cells within TME and their roles in cancer immunotherapy are reviewed, and the perspectives of the basic studies for improving the effectiveness of the clinical use are discussed.
Journal ArticleDOI

Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats.

TL;DR: It is suggested that GPs have a protective effect against T2DM-NAFLD by down-regulating the expression of TNF-α and NF-κB proteins, and PPARγ and CYP4501A1 mRNAs.
Journal ArticleDOI

High prevalence of Pfdhfr-Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.

TL;DR: Bioko Island possesses a high prevalence of the Pfdhfr triple mutation (CIRNI) and PFDhps single mutation (SGKAA), which will undermine the pharmaceutical effect of SP for malaria treatment strategies, and continuous molecular monitoring and additional control efforts are urgently needed.
Journal ArticleDOI

MicroRNA-26a-interleukin (IL)-6-IL-17 axis regulates the development of non-alcoholic fatty liver disease in a murine model.

TL;DR: The Mir‐26a–IL‐6‐IL‐17 axis regulates the development of NAFLD in a murine model and inhibited the expression of interleukin (IL)−17 and IL‐6 in vivo and in vitro.
Journal ArticleDOI

Epidemiological and Clinical Characteristics of Patients With Coronavirus Disease-2019 in Shiyan City, China.

TL;DR: It is important to assess the transmissibility of infected asymptomatic individuals for SARS-CoV-2 transmission; moreover, clinicians should be alert to the high incidence of co-infection with M. pneumoniae in COVID-19 patients.